298
Views
41
CrossRef citations to date
0
Altmetric
Research Article

Formation, Physical Stability and In Vitro Antimalarial Activity of Dihydroartemisinin Nanosuspensions Obtained by Co-grinding Method

, , , , &
Pages 314-322 | Published online: 25 Sep 2008

REFERENCES

  • Burry R., Desmazières B., Treiner C. Interaction between poly(vinylpyrrolidone) and ionic surfactants at various solid/water interfaces: A calorimetric investigation. Colloid. Surf. A: Physicochem. Eng. Aspects 1997; 127: 113–124
  • Chingunpitak J., Puttipipatkhachorn S., Petmitr P., Tozuka Y., Moribe K., Yamamoto K. (2005) Preparation and evaluation of dihydroartemisinin nanosuspension. The 4th Indochina Conference on Pharmaceutical Sciences, Ho Chi Minh CityVietnam, November, 11–132005
  • Chingunpitak J., Puttipipatkhachorn S., Tozuka Y., Moribe K., Yamamoto K. (2004) Production of micro- to nanoparticles of dihydroartemisinin. The 20th Asian Congress of Pharmaceutical Sciences, BangkokThailand, November–3 December, 302004
  • Desjarardins R. E., Canfield C. J., Haynes J. D., Chulay J. D. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother. 1979; 16: 710–718
  • Hecq J., Deleers M., Fanara D., Vranckx H., Amighi K. Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine. Int. J. Pharm. 2005; 299: 167–177
  • Itoh K., Pongpeerapat A., Tozuka Y., Oguchi T., Yamamoto K. Nanoparticle formation of poorly water soluble drugs from ternary ground mixtures with PVP and SDS. Chem. Pharm. Bull. 2003; 51: 171–174
  • Jacobs C., Kayser O., Müller R. H. Production and characterization of mucoadhesive nanosuspensions for the formulation of bupravaquone. Int. J. Pharm. 2001; 214: 3–7
  • Jones M. N. Surfactants in membrane solubilization. Int. J. Pharm. 1999; 177: 137–159
  • Kipp J. E., Wong J. C. T., Doty M. J., Rebbeck C. L. Microprecipitation method for preparing submicron suspensions. U.S. Patent No 6,607,784, 2003
  • Kirkpatrick F. H., Gordesky S. E., Marinetti G. V. Differential solubilization of proteins, phospholipids and cholesterol of erythrocyte membranes by detergents. Biochim. Biophys. Acta. 1974; 345: 154–161
  • Kocbek P., Baumgartner S., Kristl J. Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drug. Int. J. Pharm. 2006; 312: 179–186
  • Kondo N., Iwao T., Masuda H., Yamanouchi K., Ishihara Y., Yamada N., Haga T., Ogawa Y., Yokoyama K. Improved oral absorption of a poorly water-soluble drug, HO-221, by wet-bead milling producing particles in submicron region. Chem. Pharm. Bull. 1993; 41: 737–740
  • Liversidge G. G., Conzentino P. Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats. Int. J. Pharm. 1995; 125: 309–313
  • Liversidge G. G., Cundy K. C., Bishop J. F., Czekai D. A. Surface modified drug nanoparticles. U.S. Patent No 5,145,684, 1992
  • Liversidge G., Jenkins S., Liversidge E. Nanoparticulate formulations of docetaxel and analogues. U.S. Patent No 2006188566, 2006a
  • Liversidge G.G., Jenkins S. Injectable compositions of nanoparticulate immunosuppressive compounds. U.S. Patent No 2006210638, 2006b
  • Luo X. D., Shen C. C. The chemistry, pharmacology and clinical applications of qinghaosu (artemisinin) and its derivatives. Med. Res. Rev. 1987; 7: 29–52
  • Mao S., Germershaus O., Fischer D., Linn T., Schnepf R., Kissel T. Uptake and transport of PEG-graft-trimethyl-chitosan copolymer-insulin nanocomplexes by epithelial cells. Pharm. Res. 2005; 22: 2058–2068
  • Moribe K., Pongpeerapat A., Tozuka Y., Yamamoto K. Drug nanoparticle formation from drug/HPMC/SDS ternary ground mixtures. Pharmazie. 2006; 61: 97–101
  • Möschwitzer J., Achleitner G., Pomper H., Müller R. H. Development of an intravenously injectable chemically stable aqueous omeprazole formulation using nanosuspension technology. Eur. J. Pharm. Biopharm. 2004; 58: 615–619
  • Müller R. H., Jacobs C., Kayer O. Nanosuspensions for the formulation of poorly soluble drugs. Pharmaceutical emulsion and suspension, F. Nielloud, G. Marti-Mestres. Marcel Dekker, New York 2000; 383–407
  • Myint P. T., Shwe T. A controlled clinical trial of artemeter (qinghaosu derivative) versus quinine in complicated and severe falciparum malaria. Tran. R. Soc. Trop. Med. Hyg. 1987; 81: 559–561
  • Myint P. T., Shwe T., Soe L., Htut Y., Myint W. Clinical study of the treatment of cerebral malaria with artemeter (qinghaosu derivative). Tran. R. Soc. Trop. Med. Hyg. 1989; 83: 72
  • Patravale V. B., Date A. A., Kulkarni R. M. Nanosuspension: A promising drug delivery strategy. J. Pharm. Pharmacol. 2004; 56: 827–840
  • Pongpeerapat A., Itoh K., Tozuka Y., Moribe K., Oguchi T., Yamamoto K. Formation and stability of drug nanoparticles obtained from drug/PVP/SDS ternary ground mixture. J. Drug Del. Sci. Tech. 2004; 14: 441–447
  • Puttipipatkhachorn S., Chingunpitak J., Petmitr P., Tozuka Y., Moribe K., Yamamoto K. (2006) Investigation of antimalarial dihydroartemisinin nanosuspension prepared by co-grinding method. Proceedings of the 5th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Geneva, March, 27–302006
  • Rabinow B. E. Nanosuspensions in drug delivery. Nat. Rev. Drug Discov. 2004; 3: 785–796
  • Sahoo S. K., Panyam J., Prabha S., Labhasetwar V. Residual polyvinyl alcohol associated with poly (D, L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J. Controlled Release 2002; 82(1)105–114
  • Sethabouppha B. Dissolution improvement of dihydroartemisinin capsules and tablets. Mahidol University, Bangkok, Thailand, Master's thesis 1999
  • Sugimoto M., Okagaki T., Narisawa S., Koida Y., Nakajima K. Improvement of dissolution characteristics and bioavailability of poorly water-soluble drugs by novel cogrinding method using water-soluble polymer. Int. J. Pharm. 1998; 160: 11–19
  • Suzuki H., Ogawa M., Hironaka K., Ito K., Sunada H. A nifedipine coground mixture with sodium deoxycholate. II. Dissolution characteristics and stability. Drug Dev. Ind. Pharm. 2001; 27: 951–958
  • Terayama H., Okumura K., Sakai K., Torigoe K., Esumi K. Aqueous dispersion behavior of drug particles by addition of surfactant and polymer. Colloid. Surf. B: Biointerfaces 2001; 20: 73–77
  • Titulaer H. A. C., Zuidema J., Lugt C. B. Formulation and pharmacokinetics of artemisinin and its derivatives. Int. J. Pharm. 1991; 69: 83–92
  • Tozuka Y., Wongmekiat A., Sakata K., Moribe K., Oguchi T., Yamamoto K. Co-grinding with cyclodextrin as a nanoparticle preparation method of a poorly water soluble drug. J. Incl. Phenom. Macrocycl. Chem. 2004; 50: 67–71
  • Trager W., Jensen J. B. Human malaria parasites in continuous culture. Science. 1976; 193: 673–675
  • Trotta M., Gallarate M., Carlotti M. E., Morel S. Preparation of griseofulvin nanoparticles from water dilutable microemulsions. Int. J. Pharm. 2005; 254: 235–242
  • Trotta M., Gallarete M., Pattarino F., Morel S. Emulsions containing partially water-miscible solvents for the preparation of dry nanosuspensions. J. Control. Release. 2001; 76: 119–128
  • Wilairatana P., Chanthavanich P., Singhasivanon P., Treeprasertsuk S., Krudsook S., Chalermrut K., Phisalaphong C., Kraisintu K., Looareesuwan S. A comparison of three different dihydroartemisinin formulations for the treatment of acute uncomplicated falciparum malaria in ThailandInt. J. Parasitol. 1998; 28: 1213–1218
  • Wongmekiat A., Tozuka Y., Oguchi T., Yamamoto K. Formation of fine drug particles by co-grinding with cyclodextrin. I. The use of β-cyclodextrin anhydrate and hydrate. Pharm. Res. 2002; 19: 1867–1872
  • Wongmekiat A., Tozuka Y., Oguchi T., Yamamoto K. Formation of fine drug particle by cogrinding with cyclodextrins. Part II. The influence of moisture condition during cogrinding process on fine particle formation. Int. J. Pharm. 2003; 265: 85–93
  • World Health Organization (2002). Annual report, Thailand.
  • Zili Z., Sfar S., Fessi H. Preparation and characterization of poly-ε-carprolactone nanoparticles containing griseofulvin. Int. J. Pharm. 2005; 294: 261–267

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.